Stephen Lewis

Dr. Stephen Lewis

Department of Pediatrics, Department of Pharmacology, and Functional Electrical Stimulation Center, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
JSJames Seckler
James Seckler
Stephen LewisStephen Lewis
Stephen Lewis
D-amino acids have been known to exist in the human brain for nearly 40 years, and they continue to be a field of active study to today. This review article aims to give a concise overview of the recent advances in D-amino acid research as they relate to the brain and neurological disorders. This work has largely been focused on modulation of the N-methyl-D-aspartate (NMDA) receptor and its relationship to Alzheimer’s disease and Schizophrenia, but there has been a wealth of novel research which has elucidated a novel role for several D-amino acids in altering brain chemistry in a neuroprotective manner. D-amino acids which have no currently known activity in the brain but which have active derivatives will also be reviewed.

1 January 2014 in Respiratory Physiology & Neurobiology
Verified
Journal Article
Closed access
FHFraser Henderson
Fraser Henderson
WMWalter J. May
Walter J. May
RGRyan B. Gruber
Ryan B. Gruber
JDJoseph F. Discala
Joseph F. Discala
VPVeljko Puskovic
Veljko Puskovic
Stephen LewisStephen Lewis
Stephen Lewis

1 September 2018 in European Journal of Pharmacology
Verified
Journal Article
Closed access
SBSanthosh M. Baby
Santhosh M. Baby
RGRyan B. Gruber
Ryan B. Gruber
AYAlex P. Young
Alex P. Young
PMPeter M. MacFarlane
Peter M. MacFarlane
LTLuc J. Teppema
Luc J. Teppema
Stephen LewisStephen Lewis
Stephen Lewis

1 December 2014 in Respiratory Physiology & Neurobiology
Verified
Journal Article
Closed access
PGPaulina M. Getsy
Paulina M. Getsy
JDJesse Davis
Jesse Davis
GCGregory A. Coffee
Gregory A. Coffee
WMWalter J. May
Walter J. May
LPLisa A. Palmer
Lisa A. Palmer
Stephen LewisStephen Lewis
Stephen Lewis

17 September 2020 in JCI Insight
Verified
Journal Article
Open access
PDF file
BGBenjamin Gaston
Benjamin Gaston
LSLaura Smith
Laura Smith
Jürgen BoschJürgen Bosch
Jürgen Bosch
JSJames Seckler
James Seckler
DKDiana Kunze
Diana Kunze
Stephen LewisStephen Lewis
Stephen Lewis
S -nitroso-l-cysteine (L-CSNO) behaves as a ligand. Its soluble guanylate cyclase–independent (sGC-independent) effects are stereoselective — that is, not recapitulated by S -nitroso-d-cysteine (D-CSNO) — and are inhibited by chemical congeners. However, candidate L-CSNO receptors have not been identified. Here, we have used 2 complementary affinity chromatography assays — followed by unbiased proteomic analysis — to identify voltage-gated K + channel (Kv) proteins as binding partners for L-CSNO. Stereoselective L-CSNO–Kv interaction was confirmed structurally and functionally using surface plasmon resonance spectroscopy; hydrogen deuterium exchange; and, in Kv1.1/Kv1.2/Kvβ2-overexpressing cells, patch clamp assays. Remarkably, these sGC-independent L-CSNO effects did not involve S -nitrosylation of Kv proteins. In isolated rat and mouse respiratory control (petrosyl) ganglia, L-CSNO stereoselectively inhibited Kv channel function. Genetic ablation of Kv1.1 prevented this effect. In intact animals, L-CSNO injection at the level of the carotid body dramatically and stereoselectively increased minute ventilation while having no effect on blood pressure; this effect was inhibited by the L-CSNO congener S -methyl-l-cysteine. Kv proteins are physiologically relevant targets of endogenous L-CSNO. This may be a signaling pathway of broad relevance.

11 May 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
BGBenjamin Gaston
Benjamin Gaston
SBSanthosh M. Baby
Santhosh M. Baby
WMWalter J. May
Walter J. May
AYAlex P. Young
Alex P. Young
AGAlan Grossfield
Alan Grossfield
Stephen LewisStephen Lewis
Stephen Lewis
We have identified thiolesters that reverse the negative effects of opioids on breathing without compromising antinociception. Here we report the effects of d-cystine diethyl ester (d-cystine diEE) or d-cystine dimethyl ester (d-cystine diME) on morphine-induced changes in ventilation, arterial-blood gas chemistry, A-a gradient (index of gas-exchange in the lungs) and antinociception in freely moving rats. Injection of morphine (10 mg/kg, IV) elicited negative effects on breathing (e.g., depression of tidal volume, minute ventilation, peak inspiratory flow, and inspiratory drive). Subsequent injection of d-cystine diEE (500 μmol/kg, IV) elicited an immediate and sustained reversal of these effects of morphine. Injection of morphine (10 mg/kg, IV) also elicited pronounced decreases in arterial blood pH, pO2 and sO2 accompanied by pronounced increases in pCO2 (all indicative of a decrease in ventilatory drive) and A-a gradient (mismatch in ventilation-perfusion in the lungs). These effects of morphine were reversed in an immediate and sustained fashion by d-cystine diME (500 μmol/kg, IV). Finally, the duration of morphine (5 and 10 mg/kg, IV) antinociception was augmented by d-cystine diEE. d-cystine diEE and d-cystine diME may be clinically useful agents that can effectively reverse the negative effects of morphine on breathing and gas-exchange in the lungs while promoting antinociception. Our study suggests that the d-cystine thiolesters are able to differentially modulate the intracellular signaling cascades that mediate morphine-induced ventilatory depression as opposed to those that mediate morphine-induced antinociception and sedation.